| Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease PJ Eddowes, M Sasso, M Allison, E Tsochatzis, QM Anstee, D Sheridan, ... Gastroenterology 156 (6), 1717-1730, 2019 | 1021 | 2019 |
| Non-alcoholic fatty liver disease and diabetes JM Hazlehurst, C Woods, T Marjot, JF Cobbold, JW Tomlinson Metabolism 65 (8), 1096-1108, 2016 | 587 | 2016 |
| FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation … PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ... The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020 | 560 | 2020 |
| Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ... Gut 71 (5), 1006-1019, 2022 | 311 | 2022 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 217 | 2021 |
| Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity M Pavlides, R Banerjee, EM Tunnicliffe, C Kelly, J Collier, LM Wang, ... Liver International 37 (7), 1065-1073, 2017 | 196 | 2017 |
| Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management T Marjot, A Moolla, JF Cobbold, L Hodson, JW Tomlinson Endocrine reviews 41 (1), 66-117, 2020 | 191 | 2020 |
| Nonalcoholic Fatty Liver Disease (Japanese Version) XJ Wang, H Malhi Annals of internal medicine 169 (9), JITC65-JITC80, 2018 | 181 | 2018 |
| Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis D Petroff, V Blank, PN Newsome, CS Voican, M Thiele, V de Lédinghen, ... The Lancet Gastroenterology & Hepatology 6 (3), 185-198, 2021 | 179 | 2021 |
| Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease HRT Williams, IJ Cox, DG Walker, JFL Cobbold, SD Taylor-Robinson, ... BMC gastroenterology 10, 1-8, 2010 | 128 | 2010 |
| Serum metabolic profiling in inflammatory bowel disease HRT Williams, JD Willsmore, IJ Cox, DG Walker, JFL Cobbold, ... Digestive diseases and sciences 57, 2157-2165, 2012 | 112 | 2012 |
| Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function A Milona, BM Owen, JFL Cobbold, ECL Willemsen, IJ Cox, M Boudjelal, ... Hepatology 52 (4), 1341-1349, 2010 | 111 | 2010 |
| Hepatic iron is the major determinant of serum ferritin in NAFLD patients JD Ryan, AE Armitage, JF Cobbold, R Banerjee, O Borsani, ... Liver International 38 (1), 164-173, 2018 | 104 | 2018 |
| The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease T Hardy, K Wonders, R Younes, GP Aithal, R Aller, M Allison, P Bedossa, ... Contemporary clinical trials 98, 106175, 2020 | 101 | 2020 |
| Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions SHX Morin, AKP Lim, JFL Cobbold, SD Taylor-Robinson World journal of gastroenterology: WJG 13 (45), 5963, 2007 | 86 | 2007 |
| Incidental findings in healthy control research subjects using whole-body MRI SHX Morin, JFL Cobbold, AKP Lim, J Eliahoo, EL Thomas, SR Mehta, ... European journal of radiology 72 (3), 529-533, 2009 | 85 | 2009 |
| PYY plays a key role in the resolution of diabetes following bariatric surgery in humans C Guida, SD Stephen, M Watson, N Dempster, P Larraufie, T Marjot, ... EBioMedicine 40, 67-76, 2019 | 83 | 2019 |
| Immunotherapy-related hepatitis: real-world experience from a tertiary centre V Cheung, T Gupta, M Payne, MR Middleton, JD Collier, A Simmons, ... Frontline gastroenterology 10 (4), 364-371, 2019 | 81 | 2019 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 66 | 2023 |
| A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health A Moolla, K Motohashi, T Marjot, A Shard, M Ainsworth, A Gray, R Holman, ... Frontline Gastroenterology 10 (4), 337-346, 2019 | 64 | 2019 |
